Navigation Links
Qteros Management to Present at Upcoming Conferences in May
Date:4/28/2011

MARLBOROUGH, Mass., April 28, 2011 /PRNewswire/ -- Qteros, Inc., the developer of a unique and highly efficient Consolidated Bioprocessing (CBP) platform for the lowest-cost production of cellulosic ethanol, today announced its plans to present at various industry conferences throughout the month of May.

Kevin A. Gray, Ph.D., Senior Vice President and Chief Scientific Officer for Qteros, will deliver an oral presentation at the 33rd Symposium on Biotechnology for Fuels and Chemicals being held at the Sheraton Seattle, Washington. His presentation, "Technology Development and Scale-up of the Production of Lignocellulosic Ethanol using the Microbe Clostridium phytofermentans" will be presented during Session 9: Biofuels and Biorefinery Economics and Sustainability on Tuesday, May 3, 2011 at 1:00pm PDT.

Mick Sawka, Qteros' Senior Vice President of Commercial Development and Engineering, will also present on May 3, 2011 at Thomson Reuters' Open Innovation Seminar. The presentation is scheduled for 8:00am EDT and will be held at Thomson Reuters' offices in Boston, MA.

Dr. Gray will participate in the 2011 World Congress on Industrial Biotechnology & Bioprocessing in Toronto, Ontario, Canada. On Monday, May 9, 2011 at 8:45am EDT, Dr. Gray will deliver a presentation entitled, "Plant Cell Wall Degrading Micro-Organisms as Biocatalysts for Biofuels and Bio-Chemicals Production."  On Tuesday, May 10, 2011, at 9:00am EDT, Dr. Gray will moderate a panel entitled, "Engineering Low Cost Feedstocks to Value-Add Bio-chemicals." He will deliver a presentation during this panel discussion entitled, "Clostridium phytofermentans as an Inexpensive Sugar Platform for Biochemicals."

About Qteros, Inc.
Qteros' mission is to accelerate the global commercialization of large-scale, lowest-cost cellulosic ethanol production. Qteros has teamed with a core group of world-class strategic partners that complement and leverage our advanced microbiology and process engineering expertise. Working closely with its strategic partners, Qteros expects to rapidly scale its highly efficient, lowest-cost Consolidated Bioprocessing (CBP) platform for converting non-food biomass into biofuels. Qteros is funded by leading investors in the alternative energy industry including, among others, Venrock Associates, Battery Ventures, BP AE Ventures, Soros Fund Management LLC, and Valero Energy Corporation. For more information, please visit www.qteros.com.

CONTACT:
Susan Hager
VP Corporate Communications & Government Affairs
shager@qteros.com
(508) 251-6339


'/>"/>
SOURCE Qteros, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Qteros Management to Present at Alternative Energy Investment Banking Conferences
2. Qteros Management to Present at Notable Alternative Energy Conferences in February
3. Qteros and Praj Industries Announce Broad Strategic Partnership to Accelerate Global Commercialization of Cellulosic Ethanol
4. Qteros and UMass Amherst Announce the Issuance of a U.S. Patent for Production of Ethanol From a Unique Microorganism, the Q Microbe(TM)
5. Biofuels Technology Leader Qteros Names Mick Sawka Vice President, Business Development
6. Biofuels Technology Leader Qteros Names Industry Veteran John McCarthy President and Chief Executive Officer
7. Cellulosic Biofuels Leader Qteros Adds Key Positions
8. Qteros Employees Planting Special Trees in Celebration of International Day of Climate Action, October 24, 2009
9. Conflict of Interest Management System Selected by Henry Ford Health System
10. Best Practices, LLC Showcases Its Expertise in Customer Relationship Management
11. SPX Announces Acquisition of B.W. Murdoch Ltd, Broadening Process Engineering and Project Management Capabilities in New Zealand and the Asia Pacific Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a ... biotechnology industries to improve patient outcomes and quality of life, will now be ... are being attributed to new regulatory requirements for all new drug products, including ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... pathology, announced today it will be hosting a Webinar titled, “Pathology is going ... Pathology Associates , on digital pathology adoption best practices and how Proscia improves ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased ... of over 5.5 million people each year. Especially those living in larger cities are ... - based in one of the most pollution-affected countries globally - decided to take ...
Breaking Biology Technology:
(Date:4/19/2017)... , April 19, 2017 The ... vendor landscape is marked by the presence of several ... however held by five major players - 3M Cogent, ... companies accounted for nearly 61% of the global military ... companies in the global military biometrics market boast global ...
(Date:4/13/2017)... Calif. , April 13, 2017 UBM,s ... York will feature emerging and evolving technology ... Both Innovation Summits will run alongside the expo portion ... speaker sessions, panels and demonstrations focused on trending topics ... largest advanced design and manufacturing event will take place ...
(Date:4/11/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 30.37% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Biology News(10 mins):